Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

by D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Published in Cancers (Basel) (2020)